Company Data
Poseida Therapeutics Inc.
Ticker
PSTX
Current Price
$9.5
Market Cap
$925.9M
Price Target
Refer to Report
Volume
124.7K
52wk Range
$1.87 - $9.67
Overview
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.